Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy

Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy

Feb 28, 2008
Source URL: https://qa1.novartis.us/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy-0

List of links present in page
  1. https://qa1.novartis.us/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy-0